Most Read News

Bharat Petroleum Corporation announced the appointment of Dr Suman Billa Principal Secretary Industries Norka Govt of Kerala as Government Nominee Director with effect from 16 March 2022

Godrej Properties announced that they have sold 855 homes worth Rs 1650 crore within a year of the launch of their project Godrej Woods in Noida in March 2021 This includes sales of 509 crore in March 2021 and sales of 1141 crore in FY 22 YTD Situated in Noida – Sector 43 homes at Godrej Woods are set amidst a lush green urban forest […]

Mac Hotels will hold a meeting of the Board of Directors of the Company on 23 March 2022

Home First Finance Company India has allotted 22701 Equity shares of Rs 2 each on 16 March 2022 pursuant to exercise of Employee Stock Options under ESOP 2012 Scheme and ESOP II Scheme of the Company The paid-up share capital of the Company has accordingly increased from Rs 175222004 consisting of 87611002 equity shares having a face value of Rs 2 each to Rs 175267406 […]

Tata Steel announced that its step down subsidiary Tata Steel Advanced Materials has completed the acquisition of 90Percentage stake in Ceramat on 16 March 2022

Syngene International announced that ICRA has placed its ICRA AA and ICRA A1 rating on the Companys long-term and short-term banking facilities respectively on Watch with Developing Implications following the rating action on the debt facilities of the holding Company Biocon

The Board of Dr Reddys Laboratories at its meeting held on 17 March 2022 has approved the appointment of K Randhir Singh wef 17 March 2022 as the Company Secretary and Compliance Officer being the Key Managerial Personnel of the Company

REC announced that after receipt of consideration comprising of professional fee for bid process coordination interest cost and reimbursement of expenditure incurred on the project by REC Power Development Consultancy RECPDCL wholly owned subsidiary of REC the entire shareholding of Gadag Transmission comprising of 50000 equity shares presently held by RECPDCL has been transferred at par value along with all its assets and liabilities on […]

Akston Biosciences Corporation a developer of new classes of biologic therapeutics and Biolexis a division of Stelis Biopharma Stelis announced today that they have entered into a licensing manufacturing and commercialization agreement for Akstons AKS-452 a protein subunit COVID-19 vaccine Under the agreement Biolexis gains the right to manufacture and commercialize AKS-452 branded as AmbiVax-Ctrade; in India and over 130 countries in Asia Latin America […]

BEML will hold a meeting of the Board of Directors of the Company on 22 March 2022